Syncell Launches Synlight-Pure Kit to Enable 25 nm Precision Subcellular Proteomic Discovery

New Synlight-Pure™ Kit together with Syncell’s Microscoop® Mint platform achieves high-specificity subcellular proteomic discovery with 25 ...

October 30, 2025 | Thursday | News
bioAffinity Technologies Secures Australian Patent Expanding Global Lung Health Portfolio

Australian patent strengthens global patent portfolio -bioAffinity Technologies, Inc. a biotechnology company advancing early-stage diagnostic...

October 30, 2025 | Thursday | News
Zag Bio Launches with $80 Million Financing to Pioneer Thymus-Targeted Therapies for Autoimmune Diseases

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanis...

October 29, 2025 | Wednesday | News
GSK and Empirico Enter Exclusive Licensing Agreement for Novel siRNA Candidate EMP-012 in COPD

siRNA candidate EMP-012 in phase I for treatment of COPD EMP-012 targets a distinct inflammatory pathway with enhanced potency and longer dose int...

October 29, 2025 | Wednesday | News
Lonza Accelerates the Future of Pharma QC with Acquisition of Redberry and Its Breakthrough Red One™ Rapid Microbiology Platform

  Lonza to acquire Redberry SAS, an innovative company specializing in rapid microbiology testing solutions Acquisition to include Red One&trade...

October 29, 2025 | Wednesday | News
BD Showcases Next-Generation Drug Delivery and RFID Traceability Solutions at CPhI 2025

 BD (Becton, Dickinson and Company), a leading medical technology company, will feature the next generation of drug delivery and traceability s...

October 28, 2025 | Tuesday | News
Thermo Fisher Scientific Showcases Next-Generation Biopharma Solutions and AI-Driven Innovations at CPHI Frankfurt 2025

Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...

October 28, 2025 | Tuesday | News
Vas Narasimhan Calls USD 12 Billion Avidity Acquisition a Defining Move to Advance Novartis Mission in Neuromuscular Disease Treatment

Transaction strengthens neuroscience franchise for Novartis with three late-stage programs that address genetic neuromuscular diseases Advances the No...

October 27, 2025 | Monday | News
Naobios and Tokyo Metropolitan Institute of Medical Science Partner to Develop Next-Generation Mpox Vaccine

Naobios, a CDMO (Contract Development and Manufacturing Organization) providing bioprocess development and GMP production of clinical batches of virus-ba...

October 24, 2025 | Friday | News
Marc N. Casper Highlights Thermo Fisher’s 10% Adjusted EPS Growth and Strategic AI Collaboration with OpenAI in Strong Q3 2025 Results

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, reported its financial results for the third quarter ended September 27, ...

October 23, 2025 | Thursday | Company results
ProImmune Expands UK Operations with New Global Headquarters at Oxford’s Oasis Park

Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operationa...

October 23, 2025 | Thursday | News
Agarose Bead Technologies Marks 25 Years with $10 Million Expansion and Global Growth Strategy

Agarose Bead Technologies (ABT), a leading manufacturer of high-quality agarose resins has announced plans for further expansion, reinforcing its positio...

October 22, 2025 | Wednesday | News
Building Biopharma Resilience — Cytiva’s Pierre-Alain Ruffieux on Balancing Progress and Preparedness

Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...

October 20, 2025 | Monday | Interaction
Thermo Fisher Launches SwiftArrayStudio™ Microarray Analyzer to Transform Genetic Research and Precision Medicine

Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, ...

October 17, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close